Biochemical Evaluation of Serum CK18 (M30/M65) Levels and Radioprotective Effect of Melatonin in Rats Irradiated at Different Dose Rate
Biochemical evaluation of rats exposed to different dose rates
DOI:
https://doi.org/10.63187/ampas.33Keywords:
Radiotherapy, melatonin, radioprotection, biochemistryAbstract
Purpose: This study aims to biochemically assess serum CK18 levels in healthy rats exposed to FF and FFF mode irradiation. Additionally, the radioprotective effect of melatonin against two different dose rates will be evaluated. A total of 48 healthy adult female Sprague Dawley rats were included in this experimental study. Rats in Groups 1 and 2 did not receive any radiotherapy. Groups 3 and 5 were exposed to radiotherapy alone at dose rates of 600 MU/min (LDR-FF) and 2400 MU/min (HDR-FFF), respectively. Group 4 received 50 mg/kg of melatonin (MLT) 15 minutes prior to LDR-FF irradiation, while Group 6 was administered the same dose of MLT 15 minutes before HDR-FFF exposure. A significant increase in M30 and M65 levels was observed in Groups 3 and 5 as a result of radiation exposure. In both irradiated groups, melatonin treatment led to a reduction in these biochemical parameters. The findings demonstrate significant changes in serum M30 and M65 levels following melatonin administration, highlighting its potential as a radioprotective agent. CK18-based biomarkers are suggested for broader use in future preclinical and clinical research.
References
Mohan, G., et al., Recent advances in radiotherapy and its associated side effects in cancer—a review. The Journal of Basic and Applied Zoology, 2019. 80(1).
Fogliata, A., et al., Definition of parameters for quality assurance of flattening filter free (FFF) photon beams in radiation therapy. Medical Physics, 2012. 39(10): p. 6455-6464.
Wisnoskie, S.B., et al., Using flattening filter free beams in electronic tissue compensation whole breast irradiation with deep inspiration breath hold. Journal of Applied Clinical Medical Physics, 2020. 21(12): p. 280-287.
Xiao, Y., et al., Flattening filter‐free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group. Journal of Applied Clinical Medical Physics, 2015. 16(3): p. 12-29.
Linder, S., et al., Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Letters, 2004. 214(1): p. 1-9.
Ueno, T., M. Toi, and S. Linder, Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomedicine & Pharmacotherapy, 2005. 59: p. S359-S362.
Ausch, C., et al., Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients. European Journal of Surgical Oncology (EJSO), 2009. 35(11): p. 1164-1168.
Musa, A.E., D. Shabeeb, and H.S.Q. Alhilfi, Protective Effect of Melatonin Against Radiotherapy-Induced Small Intestinal Oxidative Stress: Biochemical Evaluation. Medicina, 2019. 55(6).
Mohamed, F.A., et al., Ameliorative activity of standardized Coccoloba uvifera leaves extract against streptozotocin-induced diabetic rats via activation of IRS-1/PI3K/AKT/GLUT2 pathway in liver. Future Journal of Pharmaceutical Sciences, 2024. 10(1).
Uthaman, S.K., et al., Endogenous extraction yielded high quality sulforaphane from broccoli sprouts unveils potent antioxidant and anti-Alzheimer's activities. Heliyon, 2025. 11(4).
Jiao, Y., F. Cao, and H. Liu, Radiation-induced Cell Death and Its Mechanisms. Health Physics, 2022. 123(5): p. 376-386.
Kirpich, I.A., et al., Liver Injury and Endotoxemia in Male and Female Alcohol‐Dependent Individuals Admitted to an Alcohol Treatment Program. Alcoholism: Clinical and Experimental Research, 2017. 41(4): p. 747-757.
Alonso-González, C., et al., Melatonin Modulation of Radiation-Induced Molecular Changes in MCF-7 Human Breast Cancer Cells. Biomedicines, 2022. 10(5).
Aras, S., et al., Effect of melatonin on low and high dose radiotherapy induced thyroid injury. Biotechnic & Histochemistry, 2023. 98(5): p. 346-352.
Pagano, S., et al., Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease. Biomolecules, 2023. 13(7).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Osman Vefa Gül, Kurtulus Parlak, Fatma Humeyra Yerlikaya Aydemir, Ibrahim Babalıoglu, Umit Ozdemir
This work is licensed under a Creative Commons Attribution 4.0 International License.
